Seven Eight Capital’s Idexx Laboratories IDXX Stock Holding History

Seven Eight Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-534	Closed	-$296K	–	712
2023 Q4	$296K	Sell	534 -721	-57%	-$338K	0.03%	520
2023 Q3	$549K	Buy	+1,255	New	+$626K	0.06%	373
2023 Q1	–	Sell	-548	Closed	-$224K	–	517
2022 Q4	$224K	Buy	+548	New	+$213K	0.06%	355
2020 Q1	–	Sell	-22,800	Closed	-$5.95M	–	573
2019 Q4	$5.95M	Buy	+22,800	New	+$6.01M	0.32%	87
2018 Q2	–	Sell	-2,200	Closed	-$421K	–	521
2018 Q1	$421K	Buy	+2,200	New	+$406K	0.03%	279
2017 Q4	–	Sell	-1,500	Closed	-$233K	–	504
2017 Q3	$233K	Sell	1,500 -10,800	-88%	-$1.71M	0.03%	407
2017 Q2	$1.99M	Buy	+12,300	New	+$2M	0.29%	117
2017 Q1	–	Sell	-3,800	Closed	-$446K	–	588
2016 Q4	$446K	Buy	+3,800	New	+$434K	0.09%	309
2015 Q3	–	Sell	-1,900	Closed	-$122K	–	599
2015 Q2	$122K	Buy	+1,900	New	+$132K	0.14%	234
2014 Q4	–	Sell	-11,800	Closed	-$695K	–	566
2014 Q3	$695K	Buy	11,800 +6,000	+103%	+$379K	0.53%	40
2014 Q2	$387K	Sell	5,800 -3,600	-38%	-$229K	0.37%	70
2014 Q1	$571K	Buy	9,400 +1,200	+15%	+$71.5K	0.49%	58
2013 Q4	$436K	Buy	+8,200	New	+$432K	0.48%	48

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Seven Eight Capital's IDXX Position: Q1 2024 in Review

Seven Eight Capital sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 534 shares — an estimated $296K sold.

Seven Eight Capital first reported a position in IDXX in Q4 2013 and held it in 13 quarters. The position peaked at $5.95M in Q4 2019. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

Seven Eight Capital reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
Seven Eight Capital sold 534 Idexx Laboratories shares in Q1 2024, an estimated $296K.
Seven Eight Capital first reported a position in Idexx Laboratories in Q4 2013 and held it in 13 quarters.
Seven Eight Capital's Idexx Laboratories position peaked at $5.95M in Q4 2019.
1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.